APA (7th ed.) Citation

Kauer, V., Totschnig, D., Waldenberger, F., Augustin, M., Karolyi, M., Nägeli, M., . . . Zoufaly, A. (2023, May). Efficacy of Sotrovimab (SOT), Molnupiravir (MOL), and Nirmatrelvir/Ritponavir (N/R) and Tolerability of Molnupiravir in Outpatients at High Risk for Severe COVID-19. Viruses.

Chicago Style (17th ed.) Citation

Kauer, Victoria, David Totschnig, Ferdinand Waldenberger, Max Augustin, Mario Karolyi, Michelle Nägeli, Christoph Wenisch, and Alexander Zoufaly. "Efficacy of Sotrovimab (SOT), Molnupiravir (MOL), and Nirmatrelvir/Ritponavir (N/R) and Tolerability of Molnupiravir in Outpatients at High Risk for Severe COVID-19." Viruses May. 2023.

MLA (9th ed.) Citation

Kauer, Victoria, et al. "Efficacy of Sotrovimab (SOT), Molnupiravir (MOL), and Nirmatrelvir/Ritponavir (N/R) and Tolerability of Molnupiravir in Outpatients at High Risk for Severe COVID-19." Viruses, May. 2023.